Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
57.31
+1.24 (2.20%)
Nov 21, 2024, 2:14 PM EST - Market open
Crinetics Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 5,318 | 2,377 | 985 | 1,340 | 465 | 608 | |
| Market Cap Growth | 107.96% | 141.36% | -26.50% | 188.40% | -23.56% | -15.69% | |
| Enterprise Value | 4,390 | 1,874 | 620 | 1,151 | 283 | 482 | |
| Last Close Price | 56.07 | 35.58 | 18.30 | 28.41 | 14.11 | 25.09 | |
| PS Ratio | 3936.30 | 592.25 | 207.88 | 1242.79 | 6542.73 | 509.42 | |
| PB Ratio | 5.44 | 4.41 | 3.11 | 4.04 | 2.75 | 5.19 | |
| P/TBV Ratio | 4.91 | 4.41 | 3.11 | 4.04 | 2.75 | 5.19 | |
| EV/Sales Ratio | 4224.90 | 467.04 | 130.82 | 1067.39 | 3982.45 | 403.86 | |
| Debt / Equity Ratio | 0.06 | 0.10 | 0.01 | 0.01 | 0.03 | 0.05 | |
| Asset Turnover | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | |
| Quick Ratio | 16.24 | 12.92 | 12.17 | 20.96 | 16.47 | 14.33 | |
| Current Ratio | 16.38 | 13.07 | 12.45 | 21.55 | 16.92 | 14.79 | |
| Return on Equity (ROE) | -40.26% | -50.16% | -50.57% | -42.98% | -51.61% | -36.36% | |
| Return on Assets (ROA) | -24.29% | -28.18% | -29.84% | -25.19% | -29.85% | -22.30% | |
| Return on Capital (ROIC) | -25.81% | -30.57% | -32.02% | -26.41% | -31.60% | -23.78% | |
| Earnings Yield | -5.34% | -9.03% | -16.65% | -8.03% | -15.89% | -8.30% | |
| FCF Yield | -3.91% | -7.19% | -11.87% | -6.64% | -13.39% | -7.71% | |
| Buyback Yield / Dilution | -36.52% | -11.71% | -35.24% | -26.23% | -25.95% | -99.10% | |
| Total Shareholder Return | -36.52% | -11.71% | -35.24% | -26.23% | -25.95% | -99.10% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.